Navigation Links
Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar
Date:4/10/2008

Patient Safety in Cosmetic Surgery of the Head and Neck

NEW YORK, April 10 /PRNewswire/ -- Dr. Edmund Kwan, a New York-based surgeon specializing in plastic and cosmetic surgery for the ethnic patient, will speak on facial contouring among Asian patients at a one day Continuing Medical Education (CME) Accredited seminar entitled "Patient Safety in Cosmetic Surgery of the Head and Neck" on April 12 at the University Club of New York.

"Facial contouring, a commonly requested surgery among Asian patients, is an invasive surgery that reduces the width of the face," said Dr. Edmund Kwan. "With any invasive surgery, it is important for surgeons to be educated on how to adhere to safe surgical principles. I am pleased to have the opportunity to speak about this surgery and it's complications among the Asian population."

As a specialist in plastic surgery for the ethnic patient, Dr. Kwan has dedicated his practice to the unique enhancement and preservation of each patient's ethnic integrity and identity, and approaches each patient differently. With three offices in the New York Tri-state area, Dr. Kwan continues to be diligent with innovating new techniques and practice.

The Patient Safety in Cosmetic Surgery of the Head and Neck seminar will provide plastic surgeons, otolaryngologists, dermatologists and other clinicians with an educational opportunity to hear the latest data and most recent advances in improving overall safety for patients from a team of experts. The speakers will address emerging safety concerns, problem cases and how to avoid and correct them.

About Dr. Edmund Kwan

Dr. Kwan began his medical career by attending Georgetown University Medical School and performed his plastic surgeon residency at New York Medical Hospital-Cornell Medical Center and Sloan Kettering Cancer Center. He also trained with the world-renowned Dr. Robert Flowers, a pioneer in Asian plastic surgery, in Honolulu, Hawaii. Dr. Kwa
'/>"/>

SOURCE Dr. Edmund Kwan
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
2. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
3. General Colin Powell Speaks Out for Prostate Cancer Prevention
4. Billians HealthDATA GM Speaking on Dreamforce 07 Panel
5. 2007 Speakers Golf Tournament Sets 5-Year Fundraising Record
6. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
7. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
8. Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
9. Women for Women International Congolese Country Director, Christine Karumba, Speaks Out About the Rape Epidemic in the Democratic Republic of the Congo.
10. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
11. National healthcare advocate from Harvard Med School to speak at NJIT

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... Co-existing illnesses also don,t explain why more... MONDAY, Nov. 23 (HealthDay News) -- Body weight a...lack colon cancer patients have lower survival rat...ffort to determine why blacks have lower survival ...g colon cancers, investigators have explored a var...
(Date:11/23/2009)... Study found one more than doubled chances, while ..., Nov. 23 (HealthDay News) -- Children whose mothe...lead have more than double the risk of having atte...er children, new research shows. , And with exp...having ADHD soared. Children whose mothers smoked ...
(Date:11/23/2009)...,, HOOPSOFHOPEKIDSTOSHOOT15MILLIONFREETHROW...PSOFHOPEFOUNDERPLANS12-CITYU.S.TOUR&TRIPTOAFRI...SNEWBOOK"TAKEYOURBESTSHOT" ,, SEATTLE,Nov.23/P...heglobalspreadofHIV/AIDS,thousandsnationwidewillta...ootingmarathon.Attheheartofthemovementis15-year-ol...
(Date:11/23/2009)...,, SANTACLARA,Calif.,Nov.23/PRNewswire-First...iacdiagnostictechnologyprovider,announcedtodaythat...llpresentatthe2ndAnnualLDMICROConferenceonThursday...ngeles. ,, Companymanagementwillbeavailableforo...y,December3rd.PleasecontactBrettAimeeMaasat(646)53...
(Date:11/23/2009)...,, SANDIEGO,Calif.,Nov.23/PRNewswire-FirstCa...)todayannouncedthatfourseniorexecutiveshavejoinedt...sdrivingthedevelopmentofitsobesityfranchise.Additi...dofGlobalRegulatoryAffairs;SuzanneMcDonald,HeadofM....D.,HeadofGlobalContraveProgram;andWhedyWang,Ph.D,...
Breaking Medicine News(10 mins):Health News:Weight May Not Drive Racial Disparities in Colon Cancer 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5
...teins in drug-resistant strains of the Staphylococ...ective human white blood cellsa key process ensuri...se, according to scientists at the National Instit...use some strains, including community-associated m...
...arlier means intervention may be more effective, r...Day News) -- More patients with early rheumatoid a...cal studies if the process of diagnosis included o...en at the Arthritis Center of Brigham and Women,s ...
...Over a 6 Month Period, Nasacort AQ Did Not Cause ...e Age Group, BRIDGEWATER, N.J., Nov. 10 Data pre...& Immunology (ACAAI) annual meeting,suggests that ...d with year-round allergic rhinitis. The same stud...
...ur members of the same,family, who owned and opera...DME) companies and Comprehensive Outpatient Rehabi... months in prison for Medicare fraud, Assistant,At...arlos Berenguer, 61, Ivan Aguera, 34, Aristides Be...
...v. 9 Innovation Management Group,Inc. (IMG) annou...r 1.50, a,low cost, full screen magnification soft...market are designed for individuals who have extre...agnifier,priced within the reach of the average co...
...o bad if used wisely and in the right patients, ex...ws) -- With Friday,s announcement of almost $5 bil...were hurt by the now-withdrawn painkiller Vioxx, t...ly swung the focus back on the medications once ag...
Other Medicine News:Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 2Health News:Factor key to severity of community-associated methicillin-resistant staph infections identified 3Health News:New Test Criteria Spots Rheumatoid Arthritis Sooner 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 2Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 3Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 4Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 5Health News:New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis 6Health News:Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud 2Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 2Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 3Health News:Vioxx Settlement Puts Painkillers Back in the Spotlight 4
(Date:11/20/2009)...e/ -- Reportlinker.com announces that a new market..., Medical Adhesives and Sealants - A US Market ...42/Medical-Adhesives-and-Sealants---A-US-Market-Re...amp;utm_campaign=prnewswire ,, The use of med... in medical devices and equipments. Cutting edge m...
(Date:11/20/2009)...irstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) tod...xecutive Officer, and Greg Browne, Chief Financial...ffray Health Care Conference in New York on Wednes...ence session and webcast will be audio only and no...ill host a webcast of the presentation live and by...
(Date:11/20/2009)...ire-FirstCall/ -- Smith & Nephew ( SNN, LSE: S...e signing of a technology development contract wit... lead to the creation of a fracture fixation syste...imbs of soldiers who sustain battlefield injuries....ojects Agency (DARPA), the central research and de...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Solos Endoscopy Inc Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView 28TM 29 Pr 5666 1Solos Endoscopy Inc Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView 28TM 29 Pr 5666 2Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares 5661 1Select Medical Holdings Corporation Announces Exercise of Underwriters Option to Purchase Additional Shares 5661 2Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results 5656 1Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results 5656 2
...nts Encouraged to Discuss Challenges; Offer,Soluti...eport revealing that the vast majority of American... and ethnic minorities -- are either,under-represe...es for,diseases from asthma to cancer, Harlem Hosp...er 20 so local leaders, patients, family members a...
...tive Informatics, one,of the industry,s leading eC...AREXEL International Corporation (Nasdaq: PRXL ),...ks(R) solution, a specialized Clinical Trial,Manag...l and mid-size,companies. The enhanced 2.1 version...ity for reporting, data transfer, and analyzing st...
Other Medicine Technology:First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20 2First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20 3First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20 4Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 2Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 3Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 4Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 5
Photon Laser Phacoemulsification System
Series 20000 Legacy
Aaron Burr II
Ophtho-Burr
Medicine Products: